EICHORCondition: Breast Cancer · Sponsor: NSABP Foundation Inc
RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using letrozole may fight breast cancer by lowering the amount of estrogen the body makes. It is not yet known whether letrozole is more effective than a placebo in treating patients with hormone receptor-positive breast cancer. PURPOSE: This randomized phase III trial is studying letrozole to see how well it works compared with a placebo in treating postmenopausal women who have received hormone therapy for hormone receptor-positive breast cancer.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Regional Medical Center | Anniston, Alabama, United States | — |
| Providence Cancer Center at Providence Hospital | Mobile, Alabama, United States | — |
| Providence Cancer Center | Anchorage, Alaska, United States | — |
| Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital | Fairbanks, Alaska, United States | — |
| Arkansas Cancer Research Center at University of Arkansas for Medical Sciences | Little Rock, Arkansas, United States | — |
| Alta Bates Summit Comprehensive Cancer Center | Berkeley, California, United States | — |
| Providence Saint Joseph Medical Center - Burbank | Burbank, California, United States | — |
| Peninsula Medical Center | Burlingame, California, United States | — |
| East Bay Radiation Oncology Center | Castro Valley, California, United States | — |
| Eden Medical Center | Castro Valley, California, United States | — |
| Valley Medical Oncology Consultants - Castro Valley | Castro Valley, California, United States | — |
| Cancer Care Center at John Muir Health - Concord Campus | Concord, California, United States | — |
+ 794 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00382070